Evercore ISI Starts Organovo Holdings (ONVO) at Buy

November 28, 2016 4:13 PM EST
Get Alerts ONVO Hot Sheet
Price: $3.10 +5.44%

Rating Summary:
    3 Buy, 2 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 28 | Down: 20 | New: 17
Trade ONVO Now!
Join SI Premium – FREE

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

Evercore ISI initiates coverage on Organovo Holdings (NASDAQ: ONVO) with a Buy rating and a price target of $4.50.

Analyst Ross Muken commented, "Our BUY investment thesis rests on three key revenue growth drivers that will likely lead to Organovo being the ultimate winner in the nascent bioprinting market, and they include 1) rapid market adoption of 3D printed liver and kidney tissue used in preclinical toxicity studies, 2) pharma companies partnering / collaborating with ONVO for drug development screening within these tissues, and 3) the use of 3D printed liver tissue as a therapy for patients suffering severe liver disease."

For an analyst ratings summary and ratings history on Organovo Holdings click here. For more ratings news on Organovo Holdings click here.

Shares of Organovo Holdings closed at $3.29 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, Hot New Coverage, New Coverage

Add Your Comment